Ignite Creation Date:
2025-12-24 @ 5:58 PM
Ignite Modification Date:
2026-04-21 @ 6:03 PM
Study NCT ID:
NCT01690468
Status:
TERMINATED
Last Update Posted:
2020-09-24
First Post:
2012-09-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PTX-200 and Carboplatin in Ovarian Cancer
Sponsor:
Prescient Therapeutics, Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MCC-18641
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None